Cooper-Standard Defends Board Against ISS "Against" Recommendation Over Rights Plan Extension

summarizeSummary

Cooper-Standard is challenging an Institutional Shareholder Services (ISS) recommendation to vote against its director nominees, which was issued due to the Board's extension of a Rights Plan without a new shareholder vote, despite the company's claim it protects $216 million in tax benefits.

check_boxKey Events

• ISS Recommends Against Director Nominees

  Institutional Shareholder Services (ISS) has recommended that clients vote "against" Cooper-Standard's director nominees at the upcoming Annual Meeting.

• Rights Plan Extension at Issue

  The ISS recommendation is based on the Board's September 2025 decision to extend its Section 382 Rights Agreement for one year without a new stockholder vote, a move the company states was permitted by the original plan approved in 2023.

• Protection of Tax Benefits

  Cooper-Standard asserts the Rights Plan extension is vital to protect approximately $216 million in net operating losses and other tax attributes from potential limitations under Section 382 of the Internal Revenue Code.

• Board Disagrees with ISS

  The Board respectfully disagrees with ISS, arguing the extension is a short-term measure to protect valuable assets and is not an attempt at entrenchment, noting the plan terminates early if no longer needed.

auto_awesomeAnalysis

Cooper-Standard Holdings Inc. is actively soliciting votes for its director nominees, directly addressing Institutional Shareholder Services' (ISS) recommendation to vote "against" them. ISS's stance stems from the Board's decision in September 2025 to extend its Section 382 Rights Agreement for one year without a new stockholder vote, a move permitted by the original stockholder-approved plan. The company argues this extension is crucial to protect approximately $216 million in valuable tax benefits from potential limitations due to an "ownership change." This dispute highlights a significant corporate governance issue, as a negative recommendation from ISS can sway institutional investors and potentially impact the outcome of the director elections at the upcoming Annual Meeting on May 14, 2026.